Xiaofeng Gong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xiaofeng Gong has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Bing Zhao
State Key Laboratory of Genetics and Development of Complex Phenotypes, School of Pharmaceutical Sciences, Zhongshan Hospital and School of Life Sciences, Fudan University, Shanghai, China
2 shared publications Aaron Gerald Wang
Shanghai American School, Shanghai, China
1 shared publication- Chao Tu
Department of Orthopaedics, The Second Xiangya Hospital of Central South University, Changsha, China
1 shared publication Chen Yang
BMF Nano Material Technology Company Limited, Shenzhen, China
1 shared publicationEmmanuel Enoch Dzakah
Z Lab, bioGenous BIOTECH, Shanghai, China
1 shared publicationHui Yang
Institute of Organoid Technology, Kunming Medical University, Kunming, China
1 shared publication
Latest Publications
- 2 November 2026
- Published by American Association for Cancer Research (AACR) in Cancer Research
- p. OF1-OF15
Modeling Wilms Tumor Development with Multiple-Lineage Human Fetal Kidney Organoids Reveals the Cellular Origin and Specific Drivers of Tumorigenesis
Dysregulation of kidney organogenesis can lead to the development of Wilms tumor, a common pediatric kidney cancer. Although numerous mutations implicated in Wilms tumor have been identified through genomic studies, the cellular origin and driver mutations in Wilms tumor remain unclear because of the lack of human models that preserve the complete lineage diversity of the developing kidney. In this study, we established an in vitro condition to generate three-dimensional human fetal kidney organoids (FekO) phenocopying aspects of in vivo renal cellular heterogeneity and complex organization. FekOs faithfully recapitulated the spatial arrangement of ureteric bud (UB) structures and nephron segments. FekOs could be expanded over long time periods. Screening of clinically relevant mutations in Wilms tumor identified key driver mutations and combinations that result in tumor-like neoplasms. Notably, distinct lineages were isolated from fetal kidney tissues to generate UB organoids and nephron organoids, mapping driver mutations to their specific cellular origins. Together, this model provides insights into how different mutations and their combinations drive Wilms tumorigenesis, providing a scalable platform for advancing human kidney developmental disease research. Significance: Development of a faithful fetal kidney organoid model enables identification of lineage-specific driver mutations of Wilms tumors, bridging kidney development-pediatric cancer gaps and enabling scalable translational studies.
- 2 November 2026
- Published by American Association for Cancer Research (AACR) in Cancer Research
- p. OF1-OF15
Modeling Wilms Tumor Development with Multiple-Lineage Human Fetal Kidney Organoids Reveals the Cellular Origin and Specific Drivers of Tumorigenesis
Dysregulation of kidney organogenesis can lead to the development of Wilms tumor, a common pediatric kidney cancer. Although numerous mutations implicated in Wilms tumor have been identified through genomic studies, the cellular origin and driver mutations in Wilms tumor remain unclear because of the lack of human models that preserve the complete lineage diversity of the developing kidney. In this study, we established an in vitro condition to generate three-dimensional human fetal kidney organoids (FekO) phenocopying aspects of in vivo renal cellular heterogeneity and complex organization. FekOs faithfully recapitulated the spatial arrangement of ureteric bud (UB) structures and nephron segments. FekOs could be expanded over long time periods. Screening of clinically relevant mutations in Wilms tumor identified key driver mutations and combinations that result in tumor-like neoplasms. Notably, distinct lineages were isolated from fetal kidney tissues to generate UB organoids and nephron organoids, mapping driver mutations to their specific cellular origins. Together, this model provides insights into how different mutations and their combinations drive Wilms tumorigenesis, providing a scalable platform for advancing human kidney developmental disease research. Significance: Development of a faithful fetal kidney organoid model enables identification of lineage-specific driver mutations of Wilms tumors, bridging kidney development-pediatric cancer gaps and enabling scalable translational studies.
- 20 May 2025
- Published by Zhejiang University Press in Bio-Design and Manufacturing
- Vol. 8 (3) , 410-422
Vascularized organoid-on-a-chip for centimeter-scale organoid cultivation
An organoid is a three-dimensional (3D) cell culture model that can reproduce the distinct structure and inherent functionality of certain organs. Neverthe
- 20 May 2025
- Published by Zhejiang University Press in Bio-Design and Manufacturing
- Vol. 8 (3) , 410-422
Vascularized organoid-on-a-chip for centimeter-scale organoid cultivation
An organoid is a three-dimensional (3D) cell culture model that can reproduce the distinct structure and inherent functionality of certain organs. Neverthe
- 4 October 2023
- Published by Springer Nature in Phenomics
- Vol. 4 (2) , 171-186
3D Models of Sarcomas: The Next-generation Tool for Personalized Medicine
Sarcoma is a complex and heterogeneous cancer that has been difficult to study in vitro. While two-dimensional (2D) cell cultures and mouse models have been the dominant research tools, three-dimensional (3D) culture systems such as organoids have emerged as promising alternatives. In this review, we discuss recent developments in sarcoma organoid culture, with a focus on their potential as tools for drug screening and biobanking. We also highlight the ways in which sarcoma organoids have been used to investigate the mechanisms of gene regulation, drug resistance, metastasis, and immune interactions. Sarcoma organoids have shown to retain characteristics of in vivo biology within an in vitro system, making them a more representative model for sarcoma research. Our review suggests that sarcoma organoids offer a potential path forward for translational research in this field and may provide a platform for developing personalized therapies for sarcoma patients.
- 4 October 2023
- Published by Springer Nature in Phenomics
- Vol. 4 (2) , 171-186
3D Models of Sarcomas: The Next-generation Tool for Personalized Medicine
Sarcoma is a complex and heterogeneous cancer that has been difficult to study in vitro. While two-dimensional (2D) cell cultures and mouse models have been the dominant research tools, three-dimensional (3D) culture systems such as organoids have emerged as promising alternatives. In this review, we discuss recent developments in sarcoma organoid culture, with a focus on their potential as tools for drug screening and biobanking. We also highlight the ways in which sarcoma organoids have been used to investigate the mechanisms of gene regulation, drug resistance, metastasis, and immune interactions. Sarcoma organoids have shown to retain characteristics of in vivo biology within an in vitro system, making them a more representative model for sarcoma research. Our review suggests that sarcoma organoids offer a potential path forward for translational research in this field and may provide a platform for developing personalized therapies for sarcoma patients.